Disease-related misassembly of membrane proteins

Annual Review of Biophysics and Biomolecular Structure

Volumn 33, Issue , 2004, Pages 25-51

  Sanders, Charles R ^a   Myers, Jeffrey K ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aggregation; Degradation; Drug; Endoplasmic reticulum; Folding

Indexed keywords

DIACYLGLYCEROL KINASE; LIPID; MEMBRANE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

BINDING SITE; CELL STRUCTURE; ENDOPLASMIC RETICULUM; HUMAN; LIPID BILAYER; MOLECULE; MUTATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; TOXICITY;

GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HUMANS; MEMBRANE PROTEINS; MUTATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN TRANSPORT; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

EID: 0347079798     PISSN: 10568700     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.biophys.33.110502.140348     Document Type: Review

References (166)

1. Anderson RG, Jacobson K. 2002. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296:1821-25
2. Anukanth A, Khorana HG. 1994. Structure and function in rhodopsin. Requirements of a specific structure for the intradiscal domain. J. Biol. Chem. 269:19738-44
3. Aridor M, Balch WE. 1999. Integration of endoplasmic reticulum signaling in health and disease. Nat. Med. 5:745-51
4. Aridor M, Hannan LA. 2000. Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic 1:836-51
5. Aridor M, Hannan LA. 2002. Traffic jams II: an update of diseases of intracellular transport. Traffic 3:781-90
6. Arumugam S, Pascal S, North CL, Hu W, Lee KC, et al. 1996. Conformational trapping in a membrane environment: a regulatory mechanism for protein activity? Proc. Natl. Acad. Sci. USA 93:5872-76
7. Arvan P, Zhao X, Ramos-Castaneda J, Chang A. 2002. Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems. Traffic 3:771-80
8. Ashcroft FM. 2000. Ion Channels and Disease Channelopathies. San Diego, CA: Academic
9. Badola P, Sanders CR. 1997. Escherichia coli diacylglycerol kinase is an evolutionarily optimized membrane enzyme and catalyzes direct phosphoryl transfer. J. Biol. Chem. 272:24176-82
10. Benjamin IJ, McMillan DR. 1998. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ. Res. 83:117-32
11. Beroud C, Soussi T. 2003. The UMD-p53 database: new mutations and analysis tools. Hum. Mutat. 21:176-81
12. Betts S, King J. 1999. There's a right way and a wrong way: in vivo and in vitro folding, misfolding and subunit assembly of the P22 tailspike. Struct. Fold. Des. 7:R131-R39
13. Bogdanov M, Dowhan W. 1999. Lipid-assisted protein folding. J. Biol. Chem. 274:36827-30
14. Booth PJ, Templer RH, Meijberg W, Allen SJ, Curran AR, Lorch M. 2001. In vitro studies of membrane protein folding. Crit. Rev. Biochem. Mol. Biol. 36:501-603
15. Bowie JU. 2001. Stabilizing membrane proteins. Curr. Opin. Struct. Biol. 11:397-402
16. Brady AE, Limbird LE. 2002. G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell Signal. 14:297-309
17. Brodsky JL, McCracken AA. 1999. ER protein quality control and proteasome-mediated protein degradation. Semin. Cell Dev. Biol. 10:507-13
18. Bronstein JM. 2000. Function of tetraspan proteins in the myelin sheath. Curr. Opin. Neurobiol. 10:552-57
19. Cannon KS, Cresswell P. 2001. Quality control of transmembrane domain assembly in the tetraspanin CD82. EMBO J. 20:2443-53
20. Caramelo JJ, Castro OA, Alonso LG, Prat-Gay G, Parodi AJ. 2003. UDP-Glc:glycoprotein glucosyltransferase recognizes structured and solvent accessible hydrophobic patches in molten globule-like folding intermediates. Proc. Natl. Acad. Sci. USA 100:86-91
21. Carveth K, Buck T, Anthony V, Skach WR. 2002. Cooperativity and flexibility of cystic fibrosis transmembrane conductance regulator transmembrane segments participate in membrane localization of a charged residue. J. Biol. Chem. 277:39507-14
22. Caughey B, Lansbury PT Jr. 2003. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26:267-98
23. Chamberlain AK, Faham S, Yohannan S, Bowie JU. 2003. Construction of helix-bundle membrane proteins. Adv. Protein Chem. 63:19-16
24. Chen M, Zhang JT. 1999. Topogenesis of cystic fibrosis transmembrane conductance regulator (CFTR): regulation by the amino terminal transmembrane sequences. Biochemistry 38:5471-77
25. Christensen K, Bose HS, Harris FM, Miller WL, Bell JD. 2001. Binding of steroidogenic acute regulatory protein to synthetic membranes suggests an active molten globule. J. Biol. Chem. 276:17044-51
26. Colby J, Nicholson R, Dickson KM, Orfali W, Naef R, et al. 2000. PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol. Dis. 7:561-73
27. Cotton RG, Horaitis O. 2002. The HUGO Mutation Database Initiative. Human Genome Organization. Pharmacogenomics J. 2:16-19
28. Creighton TE. 1993. Proteins: Structures and Molecular Properties. New York: Freeman
29. Daiger SP, Sullivan LS, Rossiter BJF. 2003. RetNet Retinal Information Network website. http://www.sph.uth.tmc. edu/Retnet/
30. Dalbey RE, Heijne GV. 2002. Protein Targeting, Transport and Translocation. Amsterdam: Academic
31. Dale H, Krebs MP. 1999. Membrane insertion kinetics of a protein domain in vivo. The bacterioopsin N terminus inserts co-translationally. J. Biol. Chem. 274:22693-98
32. Dickson KM, Bergeron JJ, Shames I, Colby J, Nguyen DT, et al. 2002. Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases. Proc. Natl. Acad. Sci. USA 99:9852-57
33. Dobson CM. 2001. Protein folding and its links with human disease. Biochem. Soc. Symp. 1-26
34. Edwards SW, Tan CM, Limbird LE. 2000. Localization of G-protein-coupled receptors in health and disease. Trends Pharmacol. Sci. 21:304-8
35. Eidelman O, BarNoy S, Razin M, Zhang J, McPhie P, et al. 2002. Role for phospholipid interactions in the trafficking defect of Delta F508-CFTR. Biochemistry 41:11161-70
36. Ellgaard L, Helenius A. 2001. ER quality control: towards an understanding at the molecular level. Curr. Opin. Cell Biol. 13:431-37
37. Ellgaard L, Helenius A. 2003. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4:181-91
38. Fayadat L, Kopito RR. 2003. Recognition of a single transmembrane degron by sequential quality control checkpoints. Mol. Biol. Cell 14:1268-78
39. Fayadat L, Niccoli-Sire P, Lanet J, Franc JL. 1998. Human thyroperoxidase is largely retained and rapidly degraded in the endoplasmic reticulum. Its N-glycans are required for folding and intracellular trafficking. Endocrinology 139:4277-85
40. Fersht A. 1999. Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding. New York: Freeman
41. Fewell SW, Travers KJ, Weissman JS, Brodsky JL. 2001. The action of molecular chaperones in the early secretory pathway. Annu. Rev. Genet. 35:149-91
42. Gafni A. 1997. Structural modifications of proteins during aging. J. Am. Geriatr. Soc. 45:871-80
43. Garriga P, Manyosa J. 2002. The eye photoreceptor protein rhodopsin. Structural implications for retinal disease. FEBS Lett. 528:17-22
44. Gelman MS, Kannegaard ES, Kopito RR. 2002. A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 277:11709-14
45. Gelman MS, Kopito RR. 2002. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. J. Clin. Invest. 110:1591-97
46. Gorzelle BM, Nagy JK, Oxenoid K, Lonzer WL, Cafiso DS, Sanders CR. 1999. Reconstitutive refolding of diacylglycerol kinase, an integral membrane protein. Biochemistry 38:16373-82
47. Grasberger B, Minton AP, DeLis C, Metzger H. 1986. Interaction between proteins localized in membranes. Proc. Natl. Acad. Sci. USA 83:6258-62
48. Guerois R, Nielsen JE, Serrano L. 2002. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J. Mol. Biol. 320:369-87
49. Hagihara Y, Kim PS. 2002. Toward development of a screen to identify randomly encoded, foldable sequences. Proc. Natl. Acad. Sci. USA 99:6619-24
50. Hampton RY. 2002. ER-associated degradation in protein quality control and cellular regulation. Curr. Opin. Cell Biol. 14:476-82
51. Helenius A, Aebi M. 2001. Intracellular functions of N-linked glycans. Science 291:2364-69
52. Herrmann JM, Malkus P, Schekman R. 1999. Out of the ER - outfitters, escorts and guides. Trends Cell Biol. 9:5-7
53. Hobbs HH, Russell DW, Brown MS, Goldstein JL. 1990. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu. Rev. Genet. 24:133-70
54. Jaenicke R, Seckler R. 1997. Protein misassembly in vitro. Adv. Protein Chem. 50:1-59
55. Janovick JA, Maya-Nunez G, Conn PM. 2002. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. J. Clin. Endocrinol. Metab. 87:3255-62
56. Jeon H, Meng W, Takagi J, Eck MJ, Springer TA, Blacklow SC. 2001. Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair. Nat. Struct. Biol. 8:499-504
57. Jin T, Gu Y, Zanusso G, Sy M, Kumar A, et al. 2000. The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J. Biol. Chem. 275:38699-704
58. Jo E, Fuller N, Rand RP, George-Hyslop P, Fraser PE. 2002. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. J. Mol. Biol. 315:799-807
59. Johnson AE, van Waes MA. 1999. The translocon: a dynamic gateway at the ER membrane. Annu. Rev. Cell Dev. Biol. 15:799-842
60. Kaushal S, Khorana HG. 1994. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 33:6121-28
61. Kazlauskaite J, Sanghera N, Sylvester I, Venien-Bryan C, Pinheiro TJ. 2003. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 42:3295-304
62. Kiefhaber T, Rudolph R, Kohler HH, Buchner J. 1991. Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Biotechnology 9:825-29
63. Kjeldsen T, Ludvigsen S, Diers I, Balschmidt P, Sorensen AR, Kaarsholm NC. 2002. Engineering-enhanced protein secretory expression in yeast with application to insulin. J. Biol. Chem. 277:18245-48
64. Kleinschmidt JH, Tamm LK. 2002. Secondary and tertiary structure formation of the beta-barrel membrane protein OmpA is synchronized and depends on membrane thickness. J. Mol. Biol. 324:319-30
65. Kopito RR. 1999. Biosynthesis and degradation of CFTR. Physiol. Rev. 79:S167-S73
66. Kopito RR, Sitia R. 2000. Aggresomes and Russell bodies. Symptoms of cellular indigestion? EMBO Rep. 1:225-31
67. Koppaka V, Paul C, Murray IV, Axelsen PH. 2003. Early synergy between Abeta42 and oxidatively damaged membranes in promoting amyloid fibril formation by Abeta40. J. Biol. Chem. 278:36277-84
68. Kowalski JM, Parekh RN, Mao J, Wittrup KD. 1998. Protein folding stability can determine the efficiency of escape from endoplasmic reticulum quality control. J. Biol. Chem. 273:19453-58
69. Kowalski JM, Parekh RN, Wittrup KD. 1998. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability. Biochemistry 37:1264-73
70. Lau FW, Bowie JU. 1997. A method for assessing the stability of a membrane protein. Biochemistry 36:5884-92
71. Lear JD, Gratkowski H, Adamian L, Liang J, DeGrado WF. 2003. Position-dependence of stabilizing polar interactions of asparagine in transmembrane helical bundles. Biochemistry 42:6400-7
72. Lee HJ, Choi C, Lee SJ. 2002. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277:671-78
73. Lester HA, Karschin A. 2000. Gain of function mutants: ion channels and G protein-coupled receptors. Annu. Rev. Neurosci. 23:89-125
74. Levy D. 1996. Membrane proteins which exhibit multiple topological orientations. Essays Biochem. 31:49-60
75. Liu J, Rost B. 2001. Comparing function and structure between entire proteomes. Protein Sci. 10:1970-79
76. Loo MA, Jensen TJ, Cui L, Hou Y, Chang XB, Riordan JR. 1998. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J. 17:6879-87
77. Loo TW, Bartlett MC, Clarke DM. 2002. Introduction of the most common cystic fibrosis mutation (Delta F508) into human P-glycoprotein disrupts packing of the transmembrane segments. J. Biol. Chem. 277:27585-88
78. Loo TW, Clarke DM. 1997. Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J. Biol. Chem. 272:709-12
79. Loo TW, Clarke DM. 1998. Super-folding of the partially unfolded core-glycosylated intermediate of human P-glycoprotein into the mature enzyme is promoted by substrate-induced transmembrane domain interactions. J. Biol. Chem. 273:14671-74
80. Loo TW, Clarke DM. 2003. Application of chemical chaperones to the rescue of folding defects. Methods Mol. Biol. 232:231-44
81. Lu Y, Turnbull IR, Bragin A, Carveth K, Verkman AS, Skach WR. 2000. Reorientation of aquaporin-1 topology during maturation in the endoplasmic reticulum. Mol. Biol. Cell 11:2973-85
82. Lukacs GL, Mohamed A, Kartner N, Chang XB, Riordan JR, Grinstein S. 1994. Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 13:6076-86
83. Macario AJ, Conway DM. 2000. Stress and molecular chaperones in disease. Int. J. Clin. Lab. Res. 30:49-66
84. Massiah MA, Ko YH, Pedersen PL, Mildvan AS. 1999. Cystic fibrosis transmembrane conductance regulator: solution structures of peptides based on the Phe508 region, the most common site of disease-causing DeltaF508 mutation. Biochemistry 38:7453-61
85. Mathieu ME, Grigera PR, Helenius A, Wagner RR. 1996. Folding, unfolding, and refolding of the vesicular stomatitis virus glycoprotein. Biochemistry 35: 4084-93
86. McCloskey MA, Poo MM. 1986. Rates of membrane-associated reactions: reduction of dimensionality revisited. J. Cell Biol. 102:88-96
87. McCracken AA, Brodsky JL. 2003. Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD). Bioessays 25:868-77
88. Meacham GC, Patterson C, Zhang W, Younger JM, Cyr DM. 2001. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat. Cell Biol. 3:100-5
89. Morello JP, Petaja-Repo UE, Bichet DG, Bouvier M. 2000. Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol. Sci. 21:466-69
90. Mori K. 2003. Frame switch splicing and regulated intramembrane proteolysis: key words to understand the unfolded protein response. Traffic 4:519-28
91. Morillas M, Swietnicki W, Gambetti P, Surewicz WK. 1999. Membrane environment alters the conformational structure of the recombinant human prion protein. J. Biol. Chem. 274:36859-65
92. Naef R, Suter U. 1999. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol. Dis. 6:1-14
93. Nagy JK, Lau FW, Bowie JU, Sanders CR. 2000. Mapping the oligomeric interface of diacylglycerol kinase by engineered thiol cross-linking: homologous sites in the transmembrane domain. Biochemistry 39:4154-64
94. Nagy JK, Lonzer WL, Sanders CR. 2001. Kinetic study of folding and misfolding of diacylglycerol kinase in model membranes. Biochemistry 40:8971-80
95. Nagy JK, Sanders CR. 2002. A critical residue in the folding pathway of an integral membrane protein. Biochemistry 41:9021-25
96. Nauseef WM, McCormick SJ, Goedken M. 1998. Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase. J. Biol. Chem. 273:7107-11
97. Nelson WJ, Yeaman C. 2001. Protein trafficking in the exocytic pathway of polarized epithelial cells. Trends Cell Biol. 11:483-86
98. Okada T, Fujiyoshi Y, Silow M, Navarro J, Landau EM, Shichida Y. 2002. Functional role of internal water molecules in rhodopsin revealed by X-ray. Proc. Natl. Acad. Sci. USA 99:5982-87
99. Otzen DE. 2003. Folding of DsbB in mixed micelles: a kinetic analysis of the stability of a bacterial membrane protein. J. Mol. Biol. 330:641-49
100. Deleted in proof
101. Oxenoid K, Sonnichsen FD, Sanders CR. 2002. Topology and secondary structure of the N-terminal domain of diacylglycerol kinase. Biochemistry 41:12876-82
102. Pareek S, Notterpek L, Snipes GJ, Naef R, Sossin W, et al. 1997. Neurons promote the translocation of peripheral myelin protein 22 into myelin. J. Neurosci. 17:7754-62
103. Parodi AJ. 2000. Protein glucosylation and its role in protein folding. Annu. Rev. Biochem. 69:69-93
104. Partridge AW, Melnyk RA, Deber CM. 2002. Polar residues in membrane domains of proteins: molecular basis for helix-helix association in a mutant CFTR transmembrane segment. Biochemistry 41:3647-53
105. Partridge AW, Melnyk RA, Yang D, Bowie JU, Deber CM. 2003. A transmembrane segment mimic derived from Escherichia coli diacylglycerol kinase inhibits protein activity. J. Biol. Chem. 278:22056-60
106. Partridge AW, Therien AG, Deber CM. 2002. Polar mutations in membrane proteins as a biophysical basis for disease. Biopolymers 66:350-58
107. Patil C, Walter P. 2001. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr. Opin. Cell Biol. 13:349-55
108. Paulson HL, Ross AF, Green WN, Claudio T. 1991. Analysis of early events in acetylcholine receptor assembly. J. Cell Biol. 113:1371-84
109. Petaja-Repo UE, Hogue M, Laperriere A, Walker P, Bouvier M. 2000. Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. J. Biol. Chem. 275:13727-36
110. Pind S, Riordan JR, Williams DB. 1994. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269:12784-88
111. Popot JL, Engelman DM. 2000. Helical membrane protein folding, stability, and evolution. Annu. Rev. Biochem. 69:881-922
112. Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, et al. 2003. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18:343-54
113. Qu BH, Strickland EH, Thomas PJ. 1997. Localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. J. Biol. Chem. 272:15739-44
114. Qu BH, Thomas PJ. 1996. Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway. J. Biol. Chem. 271:7261-64
115. Quilty JA, Li J, Reithmeier RA. 2002. Impaired trafficking of distal renal tubular acidosis mutants of the human kidney anion exchanger kAE1. Am. J. Physiol. Renal Physiol. 282:F810-F20
116. Rajan RS, Illing ME, Bence NF, Kopito RR. 2001. Specificity in intracellular protein aggregation and inclusion body formation. Proc. Natl. Acad. Sci. USA 98:13060-65
117. Ramer JK, Bell RM. 1990. Expression of the phospholipid-dependent Escherichia coli sn-1,2-diacylglycerol kinase in COS cells perturbs cellular lipid composition. J. Biol. Chem. 265:16478-83
118. Ramirez-Alvarado M, Merkel JS, Regan L. 2000. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc. Natl. Acad. Sci. USA 97:8979-84
119. Ritter C, Helenius A. 2000. Recognition of local glycoprotein misfolding by the ER folding sensor UDP-glucose: glycoprotein glucosyltransferase. Nat. Struct. Biol. 7:278-80
120. Sacchettini JC, Kelly JW. 2002. Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug Discov. 1:267-75
121. Saliba RS, Munro PM, Luthert PJ, Cheetham ME. 2002. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J. Cell Sci. 115:2907-18
122. Sanders CR, Ismail-Beigi F, McEnery MW. 2001. Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins. Biochemistry 40:9453-59
123. Sanders CR, Nagy JK. 2000. Misfolding of membrane proteins in health and disease: the lady or the tiger? Curr. Opin. Struct. Biol. 10:438-42
124. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770-74
125. Scott MD, Frydman J. 2003. Aberrant protein folding as the molecular basis of cancer. Methods Mol. Biol. 232:67-76
126. Seibert FS, Loo TW, Clarke DM, Riordan JR. 1997. Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein. J. Bioenerg. Biomembr. 29:429-42
127. Senes A, Ubarretxena-Belandia I, Engelman DM. 2001. The Calpha-H...O hydrogen bond: a determinant of stability and specificity in transmembrane helix interactions. Proc. Natl. Acad. Sci. USA 98:9056-61
128. Sharma M, Benharouga M, Hu W, Lukacs GL. 2001. Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments. J. Biol. Chem. 276:8942-50
129. Shastry BS. 2003. Neurodegenerative disorders of protein aggregation. Neurochem. Int. 43:1-7
130. Sheppard DN, Travis SM, Ishihara H, Welsh MJ. 1996. Contribution of proline residues in the membrane-spanning domains of cystic fibrosis transmembrane conductance regulator to chloride channel function. J. Biol. Chem. 271:14995-5001
131. Shin I, Kreimer D, Silman I, Weiner L. 1997. Membrane-promoted unfolding of acetylcholinesterase: a possible mechanism for insertion into the lipid bilayer. Proc. Natl. Acad. Sci. USA 94:2848-52
132. Siffroi-Fernandez S, Giraud A, Lanet J, Franc JL. 2002. Association of the thyrotropin receptor with calnexin, calreticulin and BiP. Effects on the maturation of the receptor. Eur. J. Biochem. 269:4930-37
133. Silvestro L, Axelsen PH. 2000. Membrane-induced folding of cecropin A. Biophys. J. 79:1465-77
134. Singer SJ. 1990. The structure and insertion of integral proteins in membranes. Annu. Rev. Cell Biol. 6:247-96
135. Song Y, Sakai J, Saito A, Usui M, Azakami H, Kato A. 2002. Relationship between the stability of lysozymes mutated at the inside hydrophobic core and secretion in Saccharomyces cerevisiae. Nahrung 46:209-13
136. Southwood CM, Garbern J, Jiang W, Gow A. 2002. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36:585-96
137. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, et al. 2003. Human Gene Mutation Database (HGMD(R)): 2003 update. Hum. Mutat. 21:577-81
138. Stojanovic A, Hwa J. 2002. Rhodopsin and retinitis pigmentosa: shedding light on structure and function. Recept. Channels 8:33-50
139. Swanton E, Bulleid NJ. 2003. Protein folding and translocation across the endoplasmic reticulum membrane. Mol. Membr. Biol. 20:99-104
140. Therien AG, Deber CM. 2002. Oligomerization of a peptide derived from the transmembrane region of the sodium pump gamma subunit: effect of the pathological mutation G41R. J. Mol. Biol. 322:583-50
141. Therien AG, Grant FE, Deber CM. 2001. Interhelical hydrogen bonds in the CFTR membrane domain. Nat. Struct. Biol. 8:597-601
142. Thomas PJ, Shenbagamurthi P, Sondek J, Hullihen JM, Pedersen PL. 1992. The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide. J. Biol. Chem. 267:5727-30
143. Trombetta ES, Helenius A. 2000. Conformational requirements for glycoprotein reglucosylation in the endoplasmic reticulum. J. Cell Biol. 148:1123-29
144. Tsai B, Ye Y, Rapoport TA. 2002. Retrotranslocation of proteins from the endoplasmic reticulum into the cytosol. Nat. Rev. Mol. Cell Biol. 3:246-55
145. Turner GC, Varshavsky A. 2000. Detecting and measuring cotranslational protein degradation in vivo. Science 289:2117-20
146. Valentijn JA, Fyfe GK, Canessa CM. 1998. Biosynthesis and processing of epithelial sodium channels in Xenopus oocytes. J. Biol. Chem. 273:30344-51
147. Vinogradova O, Carlin C, Sonnichsen FD, Sanders CR. 1998. A membrane setting for the sorting motifs present in the adenovirus E3-13.7 protein which downregulates the epidermal growth factor receptor. J. Biol. Chem. 273:17343-50
148. Wahle S, Stoffel W. 1998. Cotranslational integration of myelin proteolipid protein (PLP) into the membrane of endoplasmic reticulum: analysis of topology by glycosylation scanning and protease domain protection assay. Glia 24:226-35
149. Wang J, White AL. 1999. 6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a). J. Biol. Chem. 274: 12883-89
150. Wang Z, Moult J. 2001. SNPs, protein structure, and disease. Hum. Mutat. 17:263-70
151. Wen J, Chen X, Bowie JU. 1996. Exploring the allowed sequence space of a membrane protein. Nat. Struct. Biol. 3:141-48
152. Wetzel R. 1997. Domain stability in immunoglobulin light chain deposition disorders. Adv. Protein Chem. 50:183-242
153. White SH, Wimley WC. 1999. Membrane protein folding and stability: physical principles. Annu. Rev. Biophys. Biomol. Struct. 28:319-65
154. Wigley WC, Corboy MJ, Cutler TD, Thibodeau PH, Oldan J, et al. 2002. A protein sequence that can encode native structure by disfavoring alternate conformations. Nat. Struct. Biol. 9:381-88
155. Wu Y, Swulius MT, Moremen KW, Sifers RN. 2003. Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation. Proc. Natl. Acad. Sci. USA 100:8229-34
156. Xiong X, Bragin A, Widdicombe JH, Cohn J, Skach WR. 1997. Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. J. Clin. Invest. 100:1079-88
157. Xiong X, Chong E, Skach WR. 1999. Evidence that endoplasmic reticulum (ER)-associated degradation of cystic fibrosis transmembrane conductance regulator is linked to retrograde translocation from the ER membrane. J. Biol. Chem. 274:2616-24
158. Xu F, Cross TA. 1999. Water: foldase activity in catalyzing polypeptide conformational rearrangements. Proc. Natl. Acad. Sci. USA 96:9057-61
159. Yoshimura A, D'Andrea AD, Lodish HF. 1990. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc. Natl. Acad. Sci. USA 87:4139-43
160. Zhang F, Kartner N, Lukacs GL. 1998. Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat. Struct. Biol. 5:180-83
161. Zhang Y, Nijbroek G, Sullivan ML, McCracken AA, Watkins SC, et al. 2001. Hsp70 molecular chaperone facilitates endoplasmic reticulum-associated protein degradation of cystic fibrosis transmembrane conductance regulator in yeast. Mol. Biol. Cell 12:1303-14
162. Zhou FX, Cocco MJ, Russ WP, Brunger AT, Engelman DM. 2000. Interhelical hydrogen bonding drives strong interactions in membrane proteins. Nat. Struct. Biol. 7:154-60
163. Zhou Y, Bowie JU. 2000. Building a thermostable membrane protein. J. Biol. Chem. 275:6975-79
164. Zhou Y, Lau FW, Nauli S, Yang D, Bowie JU. 2001. Inactivation mechanism of the membrane protein diacylglycerol kinase in detergent solution. Protein Sci. 10:378-83
165. Zielenski J, Tsui LC. 1995. Cystic fibrosis: genotypic and phenotypic variations. Annu. Rev. Genet. 29:777-807
166. Nagy JK, Sanders CR. 2004. Destabilizing mutations promote membrane protein misfolding. Biochemistry 43:19-25